Glutaminyl Cyclase, Diseases, and Development of Glutaminyl

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors

PDF) Glutaminyl cyclase activity correlates with levels of Aβ peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients

2.3.2.5: glutaminyl-peptide cyclotransferase - BRENDA Enzyme Database

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

IsoQC (QPCTL) knock-out mice suggest differential substrate conversion by glutaminyl cyclase isoenzymes

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Frontiers Development and evolution of human glutaminyl cyclase inhibitors (QCIs): an alternative promising approach for disease-modifying treatment of Alzheimer's disease

Upregulation of Glutaminyl Cyclase Contributes to ERS-Induced Apoptosis in PC12 Cells

An overview of glutaminyl cyclase inhibitors for Alzheimer's disease

Glutaminyl Cyclase, Diseases, and Development of Glutaminyl Cyclase Inhibitors